Phase Ib Trial of Afatinib and BI 836845 in Advanced Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Park, Keunchil [1 ]
Lin, Chia-Chi [2 ]
Huang, Dennis Chin-Lun [3 ]
Shin, Heather Hye-Jung [4 ]
Bogenrieder, Thomas [5 ]
Tan, Daniel S. -W. [6 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
[2] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
[3] Boehringer Ingelheim Taiwan Ltd, Taipei, Taiwan
[4] Boehringer Ingelheim Korea, Seoul, South Korea
[5] Boehringer Ingelheim Rcv, Vienna, Austria
[6] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Monoclonal antibody; IGF; Phase; 1; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-100
引用
收藏
页码：S554 / S555
页数：2
相关论文
共 50 条
  • [11] Modulation of autophagy with hydroxychloroquine in patients with advanced non-small cell lung cancer (NSCLC): A phase Ib study.
    Malhotra, Jyoti
    Jabbour, Salma
    Orlick, Michelle
    Riedlinger, Gregory
    Joshi, Sonali
    Guo, Jessie Yanxiang
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [12] Afatinib in non-small cell lung cancer
    Wood, G. E.
    Polychronis, A.
    LUNG CANCER, 2016, 91 : S23 - S23
  • [13] Phase IV Study of Afatinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Thongprasert, Sumitra
    Boldeanu, Cosmin
    Radosavljevic, Davorin
    Petrovic, Marina
    Jones, Hilary
    Cseh, Agnieszka
    Gaafar, Rabab
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S667 - S667
  • [14] Chemotherapy for advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    LUNG CANCER, 2002, 38 : S47 - S50
  • [15] Real-world experience of treatment with afatinib in advanced non-small cell lung cancer (NSCLC) in Vietnam
    Dong, H.
    Tuan, K. Nguyen
    Bui, T. T. P.
    Dong, H.
    ANNALS OF ONCOLOGY, 2022, 33 : S1590 - S1590
  • [16] Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
    Antón, A
    Díaz-Fernández, N
    Larriba, JG
    Vadell, C
    Masutti, B
    Montalar, J
    Barneto, I
    Artal, A
    Rosell, R
    LUNG CANCER, 1998, 22 (02) : 139 - 148
  • [17] Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial
    Anish B. Parikh
    Peter Kozuch
    Nicholas Rohs
    Daniel J. Becker
    Benjamin P. Levy
    Investigational New Drugs, 2017, 35 : 813 - 819
  • [18] Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial
    Parikh, Anish B.
    Kozuch, Peter
    Rohs, Nicholas
    Becker, Daniel J.
    Levy, Benjamin P.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (06) : 813 - 819
  • [19] PHASE-II TRIAL OF ORAL IDARUBICIN IN ADVANCED NON-SMALL CELL LUNG-CANCER (NSCLC)
    ARDIZZONI, A
    PRONZATO, P
    REPETTO, L
    DEPALMA, M
    CANOBBIO, L
    GULISANO, M
    FUSCO, V
    ROSSO, R
    GANZINA, F
    CANCER INVESTIGATION, 1988, 6 (04) : 409 - 411
  • [20] Preliminary results from phase Ib study of spartalizumab plus chemotherapy for advanced non-small cell lung cancer (NSCLC)
    Santoro, A.
    Garrido Lopez, P.
    Tan, D. S. W.
    Paz-Ares, L.
    Shepherd, F.
    Bearz, A.
    Barlesi, F.
    Vansteenkiste, J. F.
    Kim, T. M.
    Overbeck, T. R.
    Rybkin, I. I.
    Felip, E.
    Zhou, W.
    Santarpia, L.
    Eddy, S.
    Schaefer, E. S.
    ANNALS OF ONCOLOGY, 2019, 30
12345